84 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
not relied upon any Underwriter or legal counsel for any Underwriter for any legal, tax or accounting advice in connection with the offering and sale … and timely filed all federal, state, foreign and other tax returns or other statements that are or were required to be filed by it, if any, and has paid
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
DIVIDEND POLICY
S-13
DILUTION
S-14
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS
OF OUR COMMON STOCK
S-15
UNDERWRITING
S-20 … such securities, you may experience further dilution.
S-14
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF OUR COMMON STOCK
424B5
oudgs7b 9jh
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
g2bw ipq27lt
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
86mpw8otmdsyne
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
1ots0mq
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
7grko
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
bv0mek7s
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
fkbwgq
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
62jna1e8g0zpd
23 Dec 22
Shelf registration
4:16pm
S-3
itdf7i
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
hdy1yg1kd2 vi
23 Dec 22
Shelf registration
4:16pm